Overview

M&K BioSciences, Inc. is a Maryland-based biotechnology consulting and collaboration company with a global outlook, focused on advancing protein-based therapeutics from development to commercialization.

Formerly part of L&J Biosciences, Inc., M&K was established through a strategic separation alongside L&J Bio, Inc., which now leads core R&D activities and is preparing for a future IPO in the United States.

M&K BioSciences specializes in R&D collaboration, cGMP manufacturing of protein-related products, and licensing-out strategies, supporting partners across selected Middle East and adjacent growth markets.

The company is led by a CEO with proven U.S. drug-development experience, including the invention of a cell-mediated gene therapy and the successful completion of a Phase II clinical trial under FDA compliance.

This hands-on regulatory and clinical expertise positions M&K BioSciences as a trusted partner for global collaboration and technology transfer..